Supervised Self-Injection Ups Teens' Comfort With Approach

This article originally appeared here.
Share this content:
Supervised Self-Injection Ups Teens' Comfort With Approach
Supervised Self-Injection Ups Teens' Comfort With Approach

THURSDAY, March 16, 2017 (HealthDay News) -- For food-allergic adolescents at risk for anaphylaxis, supervised self-infection with an empty syringe is associated with improved comfort levels with self-injection, according to a study published in the March-April issue of the Journal of Allergy and Clinical Immunology: In Practice.

Eyal Shemesh, M.D., from the Icahn School of Medicine at Mount Sinai, N.Y., and colleagues randomized 60 adolescent/parent pairs to self-injection, involving supervised self-injection with an empty syringe, versus control (education only) to examine the impact on comfort and anxiety during and after clinic visits in a food allergy center.

The researchers found that supervised self-injection correlated with a significant immediate increase in the primary outcome of comfort levels with the injection (within-group comparison: mean scores, 6.93 preintervention versus 8.37 postintervention; P < 0.01; between-group analysis of variance: 8.37 versus 6.69; P < 0.01). Improvements were also seen in all other secondary measures (adolescent and parent reports before versus after the injection, and changes in quality of life and anxiety a month later). Quality of life improved in 52 and 25 percent of intervention and control patients, respectively, on follow-up; similar differences were also seen for anxiety, although these differences were not statistically significant.

"A self-injection (with an empty syringe) procedure in a clinic setting improves adolescents' and parents' comfort level with self-injecting," the authors write. "It may translate into substantial clinical benefits should self-injection be needed."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis

FDA Approves Ocrevus to Treat Severe Form of ...

First drug sanctioned in United States for primary progressive multiple sclerosis

Study Explores Links Between Zika, GBS, Microcephaly in Brazil

Study Explores Links Between Zika, GBS, Microcephaly in ...

Apparent resurgence of Zika virus and GBS early in 2016, but no subsequent increase in microcephaly

Inadvertent HPV Vax Doesn't Up Risk of Poor Pregnancy Outcomes

Inadvertent HPV Vax Doesn't Up Risk of Poor ...

No increased risk of major birth defect, spontaneous abortion, preterm birth, low birth weight, SGA

is free, fast, and customized just for you!

Already a member?

Sign In Now »